Semnur Pharmaceuticals, Inc.
SMNROTCCIK 1913577HealthcareFiscal year ends Dec 31
Reports and events: 74 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1016:54 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342594 |
| 2026-07-0710:38 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-297085 |
| 2026-06-2517:03 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-283007 |
| 2026-05-1317:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221896 |
| 2026-04-3016:50 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001193125-26-197655 |
| 2026-04-2316:08 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-173690 |
| 2026-03-1716:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-110816 |
| 2026-02-2716:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-082642 |
| 2025-12-1916:07 ET | S-1/A | Registration statement, amended | 0001193125-25-326813 |
| 2025-12-0316:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-306757 |
| 2025-11-1216:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277536 |
| 2025-10-2116:21 ET | S-1 | Registration statement | 0001193125-25-245178 |
| 2025-09-2616:06 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-220455 |
| 2025-09-0417:40 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-084180 |
| 2025-08-2220:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-079504 |
| 2025-08-1507:50 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-077047 |
| 2025-08-1107:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-073907 |
| 2025-07-2816:40 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-068263 |
| 2025-07-1116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-063294 |
| 2025-06-1221:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-053576 |
| 2025-05-1616:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-044889 |
| 2025-05-1219:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-041653 |
| 2025-04-2217:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-034254 |
| 2025-04-1621:20 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-032299 |
| 2025-04-0920:30 ET | 8-K | 3.01 Delisting notice | 0001213900-25-030048 |
| 2025-04-0217:49 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-027319 |
| 2025-03-2717:13 ET | DEF 14A | Proxy statementPeriod 2025-04-10 | 0001013762-25-003461 |
| 2025-03-1218:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-022858 |
| 2025-02-1116:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-012213 |
| 2025-01-0816:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-002085 |
| 2024-12-1117:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-107941 |
| 2024-11-1917:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-100217 |
| 2024-11-1216:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-096807 |
| 2024-10-1117:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-087340 |
| 2024-10-0716:30 ET | 8-K | 3.01 Delisting notice | 0001213900-24-085921 |
| 2024-09-1217:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-077790 |
| 2024-09-0520:55 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-075736 |
| 2024-08-1917:27 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-070799 |
| 2024-08-0916:58 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-067209 |
| 2024-07-1714:45 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-24-062099 |
| 2024-07-1016:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-060537 |
| 2024-07-0516:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-059541 |
| 2024-06-2817:20 ET | DEF 14A | Proxy statementPeriod 2024-07-10 | 0001213900-24-057300 |
| 2024-06-2714:42 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-056571 |
| 2024-05-2220:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-045702 |
| 2024-04-0116:41 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028809 |
| 2024-02-2716:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-24-017542 |
| 2024-01-1021:40 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-002430 |
| 2023-12-2916:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-099880 |
| 2023-11-2016:44 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-088773 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.